155 related articles for article (PubMed ID: 38547719)
1. Inpatient antipsychotic medication switching and rehospitalization risk among patients with schizophrenia-spectrum disorders.
Gao YN; Wang R; Gu G; Chung R; Olfson M
Schizophr Res; 2024 May; 267():165-172. PubMed ID: 38547719
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA
J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
[TBL] [Abstract][Full Text] [Related]
3. Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder.
Bodén R; Brandt L; Kieler H; Andersen M; Reutfors J
Schizophr Res; 2011 Dec; 133(1-3):36-41. PubMed ID: 21982098
[TBL] [Abstract][Full Text] [Related]
4. Assessing medication adherence and healthcare utilization and cost patterns among hospital-discharged patients with schizoaffective disorder.
Karve S; Markowitz M; Fu DJ; Lindenmayer JP; Wang CC; Candrilli SD; Alphs L
Appl Health Econ Health Policy; 2014 Jun; 12(3):335-46. PubMed ID: 24756319
[TBL] [Abstract][Full Text] [Related]
5. Hospital Readmission Rates Among Patients With Schizophrenia Treated With Long-Acting Injectables or Oral Antipsychotics.
MacEwan JP; Kamat SA; Duffy RA; Seabury S; Chou JW; Legacy SN; Hartry A; Eramo A; Karson C
Psychiatr Serv; 2016 Nov; 67(11):1183-1188. PubMed ID: 27417897
[TBL] [Abstract][Full Text] [Related]
6. Hospitalization outcomes in patients with schizophrenia after switching to lurasidone or quetiapine: a US claims database analysis.
Newcomer JW; Ng-Mak D; Rajagopalan K; Loebel A
BMC Health Serv Res; 2018 Apr; 18(1):243. PubMed ID: 29618351
[TBL] [Abstract][Full Text] [Related]
7. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.
Tiihonen J; Haukka J; Taylor M; Haddad PM; Patel MX; Korhonen P
Am J Psychiatry; 2011 Jun; 168(6):603-9. PubMed ID: 21362741
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic prescription filling in patients with schizophrenia or schizoaffective disorder.
Reutfors J; Brandt L; Stephansson O; Kieler H; Andersen M; Bodén R
J Clin Psychopharmacol; 2013 Dec; 33(6):759-65. PubMed ID: 24126686
[TBL] [Abstract][Full Text] [Related]
9. Switching antipsychotics in inpatient schizophrenia care: predictors and outcomes.
Weinmann S; Janssen B; Gaebel W
J Clin Psychiatry; 2004 Aug; 65(8):1099-105. PubMed ID: 15323596
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for early readmission to acute care for persons with schizophrenia taking antipsychotic medications.
Boaz TL; Becker MA; Andel R; Van Dorn RA; Choi J; Sikirica M
Psychiatr Serv; 2013 Dec; 64(12):1225-9. PubMed ID: 23945797
[TBL] [Abstract][Full Text] [Related]
11. Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation.
Dickson MC; Nguyen MM; Patel C; Grabich SC; Benson C; Cothran T; Skrepnek GH
Adv Ther; 2023 Jan; 40(1):349-366. PubMed ID: 36348142
[TBL] [Abstract][Full Text] [Related]
12. A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia.
Taylor D; Hayhurst K; Kerwin R
Int Clin Psychopharmacol; 2007 May; 22(3):133-6. PubMed ID: 17414738
[TBL] [Abstract][Full Text] [Related]
13. Association of antipsychotic treatment switching in patients with schizophrenia, bipolar, and major depressive disorders.
Ayyagari R; Thomason D; Mu F; Philbin M; Carroll B
J Med Econ; 2020 Feb; 23(2):204-212. PubMed ID: 31663802
[No Abstract] [Full Text] [Related]
14. Assessing clinical predictions of early rehospitalization in schizophrenia.
Olfson M; Mechanic D; Boyer CA; Hansell S; Walkup J; Weiden PJ
J Nerv Ment Dis; 1999 Dec; 187(12):721-9. PubMed ID: 10665466
[TBL] [Abstract][Full Text] [Related]
15. A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder.
Babatope T; Chotalia J; Elkhatib R; Mohite S; Shah J; Goddu S; Patel RA; Aimienwanu OR; Patel D; Makanjuola T; Okusaga OO
Psychiatr Q; 2016 Dec; 87(4):729-737. PubMed ID: 26875104
[TBL] [Abstract][Full Text] [Related]
16. Assessment of inpatient psychiatric readmission risk among patients discharged on an antipsychotic polypharmacy regimen: A retrospective cohort study.
Boskailo E; Malkoc A; McCurry DB; Venter J; Drachman D; Ramos GM
Acta Med Acad; 2017 Nov; 46(2):133-144. PubMed ID: 29338277
[TBL] [Abstract][Full Text] [Related]
17. Continuity of care among patients newly initiated on second-generation oral or long-acting injectable antipsychotics during a schizophrenia-related inpatient stay.
Patel C; Pilon D; Morrison L; Holiday C; Lafeuille MH; Lefebvre P; Benson C
Curr Med Res Opin; 2023 Aug; 39(8):1157-1166. PubMed ID: 37461233
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic Medication Adherence and Diabetes-Related Hospitalizations Among Medicaid Recipients With Diabetes and Schizophrenia.
Egglefield K; Cogan L; Leckman-Westin E; Finnerty M
Psychiatr Serv; 2020 Mar; 71(3):236-242. PubMed ID: 31744428
[TBL] [Abstract][Full Text] [Related]
19. Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
Maestri TJ; Mican LM; Rozea H; Barner JC
Psychopharmacol Bull; 2018 Mar; 48(3):8-15. PubMed ID: 29713100
[TBL] [Abstract][Full Text] [Related]
20. Switching patients with stable schizophrenia or schizoaffective disorder from olanzapine to risperidone long-acting injectable.
Rosa F; Schreiner A; Thomas P; Sherif T
Clin Drug Investig; 2012 Apr; 32(4):267-79. PubMed ID: 22339430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
